arrow
K

Kathryn A. Morton

medicine
H指数:30
被引数:2,699

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements

2008年至2023年间开发的案例层面因果关系评估工具的范围综述;优势、劣势及未来潜在改进方向

2026-03-300
PRE
Validation of Guillain-Barré syndrome case identification in three heterogeneous VAC4EU real-world data sources in Spain using the Brighton Collaboration criteria

使用布赖顿协作标准验证西班牙三种异质性VAC4EU真实世界数据源中的吉兰-巴雷综合征病例识别。

Vaccine
IF3.5
2026-03-090
OAAI
Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience
2026-01-300
OAAI
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study

过敏史人群中新型冠状病毒肺炎疫苗的安全性: 一项欧洲主动监测研究

2024-09-170
OAAI
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European Covid Vaccine Monitor Active Surveillance Study
2024-06-222
OAAI
Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study
2024-02-263
OAAI
NF-B and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma
2015-06-2354
OAAI